What is the share price of Vanta Bioscience Ltd (VANTABIO) today?

The share price of VANTABIO as on 17th June 2025 is ₹27.79. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Vanta Bioscience Ltd (VANTABIO) share?

The past returns of Vanta Bioscience Ltd (VANTABIO) share are Past 1 week: 3.69% Past 1 month: 12.06% Past 3 months: 25.63% Past 6 months: -34.72% Past 1 year: -46.81% Past 3 years: -71.84% Past 5 years: -72.21%

What are the peers or stocks similar to Vanta Bioscience Ltd (VANTABIO)?

The peers or stocks similar to Vanta Bioscience Ltd (VANTABIO) include: Vanta Bioscience Ltd Divi's Laboratories Ltd Syngene International Ltd Aarti Pharmalabs Ltd Dishman Carbogen Amcis Ltd Vimta Labs Ltd

What is the market cap of Vanta Bioscience Ltd (VANTABIO) share?

Market capitalization, short for market cap , is the market value of a publicly traded company's outstanding shares. The market cap of Vanta Bioscience Ltd (VANTABIO) is ₹17.54 Cr as of 17th June 2025.

What is the 52 week high and low of Vanta Bioscience Ltd (VANTABIO) share?

The 52-week high of Vanta Bioscience Ltd (VANTABIO) is ₹64.84 and the 52-week low is ₹19.08.

What is the PE and PB ratio of Vanta Bioscience Ltd (VANTABIO) stock?

The P/E (price-to-earnings) ratio of Vanta Bioscience Ltd (VANTABIO) is -7.56. The P/B (price-to-book) ratio is 1.35.

Which sector does Vanta Bioscience Ltd (VANTABIO) belong to?

Vanta Bioscience Ltd (VANTABIO) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.

How to buy Vanta Bioscience Ltd (VANTABIO) shares?

You can directly buy Vanta Bioscience Ltd (VANTABIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Vanta Bioscience Ltd

VANTABIO Share Price

27.790.00% (+0.00)

VANTABIO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

VANTABIO Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
—	1.35	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.56	6.60	0.83%

VANTABIO Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

VANTABIO Company Profile

The company is a preclinical contract research company. It provides preclinical safety assessment services, assessment services for evaluating the safety of the active pharmaceutical ingredients (API), etc.

VANTABIO Similar Stocks (Peers)

Compare with peers Compare with peers

VANTABIO Similar Stocks (Peers)

Compare with peers Compare with peers

Divi's Laboratories Ltd

DIVISLAB

PE Ratio

82.51

1Y Return

47.97%

Buy Reco %

47.83

Syngene International Ltd

SYNGENE

PE Ratio

51.73

1Y Return

10.74%

Buy Reco %

71.43

Aarti Pharmalabs Ltd

AARTIPHARM

PE Ratio

29.62

1Y Return

40.17%

Buy Reco %

0.00

Dishman Carbogen Amcis Ltd

DCAL

PE Ratio

1,214.34

1Y Return

43.02%

Buy Reco %

0.00

Vimta Labs Ltd

VIMTALABS

PE Ratio

29.72

1Y Return

87.02%

Buy Reco %

0.00

Compare with Peers

VANTABIO Forecast

VANTABIO Forecasts

VANTABIO

Income

Balance Sheet

Cash Flow

VANTABIO Income Statement

Financial Year		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	TTM
Total Revenue	4.04	12.65	14.25	10.07	10.11	6.97	9.83	—
Raw Materials	2.96	0.00	0.00	0.00	0.00	0.00	0.00	—
Power & Fuel Cost		0.98	1.04	0.54	0.55	0.75	1.01
Employee Cost		2.90	3.93	2.51	2.67	3.46	3.79
Selling & Administrative Expenses		3.23	3.30	1.94	2.00	3.08	2.39
Operating & Other expenses		2.04	1.50	1.10	1.00	1.38	1.22
EBITDA	1.08	3.50	4.48	3.98	3.89	-1.70	1.42	—
Depreciation/Amortization	0.57	0.71	1.19	1.25	1.32	2.67	4.50	—
PBIT	0.51	2.79	3.29	2.73	2.57	-4.37	-3.08	—
Interest & Other Items	0.20	1.69	1.95	2.14	2.35	5.89	5.75	—
PBT	0.31	1.10	1.34	0.59	0.22	-10.26	-8.83	—
Taxes & Other Items	0.29	0.40	0.34	0.14	0.14	-3.78	-6.51	—
Net Income	0.02	0.70	1.00	0.45	0.08	-6.48	-2.32	—
EPS	0.05	1.11	1.58	0.71	0.13	-10.27	-3.68	—
DPS	—	0.00	0.00	0.00	0.00	0.00	0.00	—
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

VANTABIO Income Statement

Quarter		dec 2021		dec 2022	mar 2023
Total Revenue	0.00	2.83	1.29
Operating & Other expenses	0.00	3.37	1.93
EBITDA	0.00	-0.54	-0.64
Depreciation/Amortization	0.00	1.31	0.05
PBIT	0.00	-1.85	-0.69
Interest & Other Items	0.00	2.48	0.92
PBT	0.00	-4.33	-1.61
Taxes & Other Items	0.38	0.09	-0.01
Net Income	-0.38	-4.42	-1.60
EPS	0.00	-4.06	0.00

VANTABIO Cash Flow Statement

Financial Year		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024
Cash from Operating Activities	-1.04	2.34	6.97	5.28	-0.63	2.68
Cash from Investing Activities	-5.73	-7.59	-22.30	-17.24	-5.91	-3.31
Cash from Financing Activities	9.94	2.17	17.78	9.53	6.41	0.69
Net Change in Cash	+3.17	-3.08	+2.45	-2.43	-0.13	+0.06
Changes in Working Capital	-4.54	-2.14	+3.01	+1.39	+1.09	+1.31
Capital Expenditures	2.48	0.35	0.86	0.33	28.69	3.40
Free Cash Flow	-3.52	1.99	6.11	4.95	-29.32	-0.72

VANTABIO Company Updates

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

VANTABIO Stock Peers

VANTABIO Past Performance & Peer Comparison

Comparing 3 stocks from
Health CareLabs & Life Sciences Services

Valuation

Technical

Forecast

Compare valuation-basic on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Vanta Bioscience Ltd	-7.56	1.35	—
Divi's Laboratories Ltd	82.51	13.32	0.44%
Syngene International Ltd	51.73	6.03	0.20%
Aarti Pharmalabs Ltd	29.62	4.59	0.56%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Vanta Bioscience Ltd	Pro
Divi's Laboratories Ltd
Syngene International Ltd
Aarti Pharmalabs Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Vanta Bioscience Ltd	63.63%	98.54	Pro
Divi's Laboratories Ltd	28.81%	58.43
Syngene International Ltd	31.02%	39.51
Aarti Pharmalabs Ltd	46.24%	43.10

VANTABIO Stock Price Comparison

Compare VANTABIO with any stock or ETF

VANTABIO

VANTABIO Holdings

VANTABIO Shareholdings

VANTABIO Promoter Holdings Trend

VANTABIO Institutional Holdings Trend

No institutional holdings trend are available

VANTABIO Shareholding Pattern

VANTABIO Shareholding History

Foreign Institutions

VANTABIO Insider Trades & Bulk Stock Deals

smallcases containing VANTABIO stock

Looks like this stock is not in any smallcase yet.

VANTABIO Events

VANTABIO Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

VANTABIO Dividend Trend

VANTABIO Dividends

Hmm, looks like data is unavailable here. Please come back after some time

VANTABIO Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

VANTABIO Upcoming Announcements

No upcoming announcements are available

VANTABIO Past Announcements

Company Update

Announced OnJun 16, 2025

Vanta Bioscience Ltd - 540729 - Rejectio

Vanta Bioscience Ltd - 540729 - Rejectio Download

Link

Download

Announced On

Jun 16, 2025

Company Update

Announced OnMay 29, 2025

Vanta Bioscience Ltd - 540729 - Cancella

Vanta Bioscience Ltd - 540729 - Cancella Download

Link

Download

Announced On

May 29, 2025

Result

Announced OnMay 29, 2025

Vanta Bioscience Ltd - 540729 - Results-

Vanta Bioscience Ltd - 540729 - Results- Download

Link

Download

Announced On

May 29, 2025

Board Meeting

Announced OnMay 21, 2025

Vanta Bioscience Ltd - 540729 - Board Me

Vanta Bioscience Ltd - 540729 - Board Me Download

Link

Download

Announced On

May 21, 2025

Insider Trading / SAST

Announced OnMay 9, 2025

Vanta Bioscience Ltd - 540729 - Disclosu

Vanta Bioscience Ltd - 540729 - Disclosu Download

Link

Download

Announced On

May 9, 2025

VANTABIO Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

VANTABIO Stock News & Opinions

Corporate

Vanta Bioscience cancels board meeting

Vanta Bioscience has cancelled the board meeting which was scheduled to be held on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Vanta Bioscience schedules board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Vanta Bioscience schedules EGM

Vanta Bioscience announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 4 January 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Vanta Bioscience to hold board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 6 December 2024Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Vanta Bioscience to declare Quarterly Result

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Vanta Bioscience postpones board meeting

Vanta Bioscience has postponed the meeting of the Board of Directors which was scheduled to be held on 17 July 2024. The meeting will now be held on 19 July 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

What is the share price of Vanta Bioscience Ltd (VANTABIO) today?
The share price of VANTABIO as on 17th June 2025 is ₹27.79. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Vanta Bioscience Ltd (VANTABIO) share?
The past returns of Vanta Bioscience Ltd (VANTABIO) share are
- Past 1 week: 3.69%
- Past 1 month: 12.06%
- Past 3 months: 25.63%
- Past 6 months: -34.72%
- Past 1 year: -46.81%
- Past 3 years: -71.84%
- Past 5 years: -72.21%
What are the peers or stocks similar to Vanta Bioscience Ltd (VANTABIO)?
The peers or stocks similar to Vanta Bioscience Ltd (VANTABIO) include:
What is the market cap of Vanta Bioscience Ltd (VANTABIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vanta Bioscience Ltd (VANTABIO) is ₹17.54 Cr as of 17th June 2025.
What is the 52 week high and low of Vanta Bioscience Ltd (VANTABIO) share?
The 52-week high of Vanta Bioscience Ltd (VANTABIO) is ₹64.84 and the 52-week low is ₹19.08.
What is the PE and PB ratio of Vanta Bioscience Ltd (VANTABIO) stock?
The P/E (price-to-earnings) ratio of Vanta Bioscience Ltd (VANTABIO) is -7.56. The P/B (price-to-book) ratio is 1.35.
Which sector does Vanta Bioscience Ltd (VANTABIO) belong to?
Vanta Bioscience Ltd (VANTABIO) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.
How to buy Vanta Bioscience Ltd (VANTABIO) shares?
You can directly buy Vanta Bioscience Ltd (VANTABIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.